565 related articles for article (PubMed ID: 7381926)
21. [Consumption hypocomplementemia: comparative value of haemolytic and protein estimations of the components of the classical pathway (author's transl)].
Roncato M; Vial MC; Maillet F; Peltier A
Nouv Presse Med; 1979 May; 8(20):1657-60. PubMed ID: 112575
[TBL] [Abstract][Full Text] [Related]
22. [Complement activation after the intravascular administration of contrast media: a comparison between ionic and nonionic x-ray contrast media].
Hoffmeister HM; Fuhrer G; Platten HP; Heller W
Rofo; 1987 Dec; 147(6):673-5. PubMed ID: 2827265
[TBL] [Abstract][Full Text] [Related]
23. A shared effect of abscesses and nonviable tissue influencing the development of sepsis and acute respiratory distress syndrome.
Heideman M
Acta Chir Scand Suppl; 1982; 508():295-302. PubMed ID: 6952692
[TBL] [Abstract][Full Text] [Related]
24. Complement alterations in inflammatory bowel disease.
Lake AM; Stitzel AE; Urmson JR; Walker WA; Spitzer RE
Gastroenterology; 1979 Jun; 76(6):1374-9. PubMed ID: 437435
[TBL] [Abstract][Full Text] [Related]
25. Complement components in Nigerians with bronchial asthma.
Onyemelukwe GC
Ann Allergy; 1989 Oct; 63(4):309-12. PubMed ID: 2802267
[TBL] [Abstract][Full Text] [Related]
26. [Complement. Evaluation of some complement fractions in patients affected by neoplasia undergoing chemotherapy (author's transl)].
Ignesti C; Lenzi L; Salvadori D; Innocenti V; Baroncelli C; Casadei BM
Quad Sclavo Diagn; 1981 Jun; 17(2):152-6. PubMed ID: 6943601
[TBL] [Abstract][Full Text] [Related]
27. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
[TBL] [Abstract][Full Text] [Related]
28. Immunology of chronic generalized periodontitis. 2. Estimation of total hemolytic complement (CH 50) and its fractions C3 and C4.
Anil S; Beena VT; Remani P; Haseenabeevi M; Vijayakumar T
Indian J Dent Res; 1991; 2(3-4):35-9. PubMed ID: 1821159
[TBL] [Abstract][Full Text] [Related]
29. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
30. Glomerulonephritides and hypocomplementemia: pathophysiology and pathogenic implications.
Leibowitch J; Leveille M; Halwachs L; Wattel S
Adv Nephrol Necker Hosp; 1980; 9():295-314. PubMed ID: 6773316
[No Abstract] [Full Text] [Related]
31. Serum complement components in Henoch-Schönlein purpura.
Garcia-Fuentes M; Martin A; Chantler C; Williams DG
Arch Dis Child; 1978 May; 53(5):417-9. PubMed ID: 666358
[TBL] [Abstract][Full Text] [Related]
32. [Tissue sites of the different classes of immunoglobulins and of complement factors C1q, C3, C9 and B in relation to the state of advancement of chronic bronchitis (author's transl)].
Duheille J; Puchelle E; Horsky P; Amor M; Sadoul P
Nouv Presse Med; 1979 Jun; 8(25):2109-12. PubMed ID: 471757
[No Abstract] [Full Text] [Related]
33. Impairment of acute protein reactivity in chronic renal failure.
Charlesworth JA; Quin JW; Holloway RH; Jones BF; Robertson MR
Int Arch Allergy Appl Immunol; 1979; 59(4):420-6. PubMed ID: 87382
[TBL] [Abstract][Full Text] [Related]
34. Acute hepatitis: significance of changes in complement components.
Charlesworth JA; Lawrence S; Worsdall PA; Roy LP; Boughton CR
Clin Exp Immunol; 1977 Jun; 28(3):496-501. PubMed ID: 891025
[TBL] [Abstract][Full Text] [Related]
35. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
Mollnes TE; Ng YC; Peters DK; Lea T; Tschopp J; Harboe M
Clin Exp Immunol; 1986 Jul; 65(1):73-9. PubMed ID: 3641694
[TBL] [Abstract][Full Text] [Related]
36. Abnormalities of complement and its components in patients with acute leukemia, Hodgkin's disease, and sarcoma.
Lichtenfeld JL; Wiernik PH; Mardiney MR; Zarco RM
Cancer Res; 1976 Oct; 36(10):3678-80. PubMed ID: 953991
[TBL] [Abstract][Full Text] [Related]
37. The difference between serum and plasma complement activity in primary renal disease.
Akagaki Y; Fujiwara Y; Nakanishi I; Orita Y; Ando A; Abe H; Kitamura H; Nagaki K; Inai S
Clin Nephrol; 1980 Aug; 14(2):75-80. PubMed ID: 7408259
[TBL] [Abstract][Full Text] [Related]
38. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with premalignant and malignant lesions of the oral cavity.
Rajendran R; Remani P; Vijayakumar T; Vasudevan DM
Ann Dent; 1990; 49(1):36-8, 51. PubMed ID: 2346298
[TBL] [Abstract][Full Text] [Related]
39. Changes of serum complement concentrations in tumour patients prior and after radiotherapy.
Beyer-Enke SA; Strauss LG; Georgi M
Strahlenther Onkol; 1986 Jul; 162(7):441-7. PubMed ID: 3488595
[TBL] [Abstract][Full Text] [Related]
40. [Action of complement in normal pregnancy and gestosis].
Manno C; Loverro G; Selvaggi L; Pepe M; Schena FP
Boll Ist Sieroter Milan; 1979 Sep; 58(4):325-34. PubMed ID: 261756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
